214 related articles for article (PubMed ID: 7632162)
1. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro.
Eliason JF; Ramuz H; Yoshikubo T; Ishikawa T; Yamamoto T; Tsuruo T
Biochem Pharmacol; 1995 Jul; 50(2):187-96. PubMed ID: 7632162
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro evaluation of dithiane analogs of tiapamil, Ro 11-2933, Ro 44-5911 and Ro 44-5912 as multidrug resistance modulators.
Abderrabi M; Marchal S; Merlin JL
Anticancer Drugs; 1996 Jun; 7(4):430-6. PubMed ID: 8826612
[TBL] [Abstract][Full Text] [Related]
3. Azelastine and flezelastine as reversing agents of multidrug resistance: pharmacological and molecular studies.
Hu YP; Robert J
Biochem Pharmacol; 1995 Jul; 50(2):169-75. PubMed ID: 7632160
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.
Asoh K; Saburi Y; Sato S; Nogae I; Kohno K; Kuwano M
Jpn J Cancer Res; 1989 May; 80(5):475-81. PubMed ID: 2568984
[TBL] [Abstract][Full Text] [Related]
8. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
9. The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo.
Eliason JF; Sawada R; Tsukaguchi T; Kobayashi K; Ichihara S; Konishi C; Horii I; Kuruma I; Ramuz H
Eur J Cancer; 1995 Dec; 31A(13-14):2354-61. PubMed ID: 8652269
[TBL] [Abstract][Full Text] [Related]
10. Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
Toffoli G; Corona G; Sorio R; Bertola A; Boiocchi M
Int J Cancer; 1997 May; 71(5):900-6. PubMed ID: 9180163
[TBL] [Abstract][Full Text] [Related]
11. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
[TBL] [Abstract][Full Text] [Related]
12. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells.
Merritt JE; Sullivan JA; Drew L; Khan A; Wilson K; Mulqueen M; Harris W; Bradshaw D; Hill CH; Rumsby M; Warr R
Cancer Chemother Pharmacol; 1999; 43(5):371-8. PubMed ID: 10100591
[TBL] [Abstract][Full Text] [Related]
13. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
[TBL] [Abstract][Full Text] [Related]
14. Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line.
Gaj CL; Anyanwutaku I; Chang YH; Cheng YC
Biochem Pharmacol; 1998 Apr; 55(8):1199-211. PubMed ID: 9719474
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
17. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
Uchiyama-Kokubu N; Watanabe T; Cohen D
Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863
[TBL] [Abstract][Full Text] [Related]
18. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
Bennis S; Ichas F; Robert J
Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
[TBL] [Abstract][Full Text] [Related]
20. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ
Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]